Lung Cancer Screening Market Size, Segments, and Trends by 2030
Lung Cancer Screening Market: Strategic Insights
Lung Cancer Screening Market
-
CAGR (2022 - 2030)8.2% -
Market Size 2022
US$ 2.33 Billion -
Market Size 2030
US$ 4.36 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Lung Cancer Incidence
- Increasing Government Support
FUTURE TRENDS
- Mobile Lung Cancer Screening Truck
OPPORTUNITIES
- Structured Lung Cancer Screening Program
Key Players
- Intelerad Medical Systems Incorporated
- Nuance Communications Inc
- GE HealthCare Technologies Inc
- Medtronic Plc
- Canon Medical Systems Corp
- Koninklijke Philips NV
- Siemens AG
- CVS Health
- bioAffinity Technologies Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Cancer Type
- Non-Small Cell Lung Cancer
Technology
- Low-Dose Computed Tomography
- Chest X-Ray
- Liquid Biopsy
Age Group
- 50 & Older and Below 50
End User
- Hospitals
- Diagnostic Centers